Company / Shareholders' Equity
Insulet Corporation Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.5B
FY2025
5-year range
$476.4M / $1.5B
FY2021-FY2025
Trend
+25.1%
vs FY2024
Sector context
#69 of 166
Health Care
What the data says
At $1.5B, Insulet Corporation's shareholders' equity ranks #69 of 166 in the Health Care sector. Shareholders' Equity has increased for 3 consecutive years, from $476M in FY2022 to $1.5B in FY2025.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 5-year CAGR of +20.2%.
Improved from $733M to $1.5B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +47.1%
- 5-Year CAGR
- +20.2%
- 10-Year CAGR
- -
Sector benchmark
#69 of 166 in Health CareTop 42% of 166This company $1.5B Sector average $5.3B
▼
-71.2% below sector average
Key checks
Key Insights
- Insulet Corporation's shareholders' equity has grown for 3 consecutive years.
- 5-year CAGR of +20.2%, indicating consistent growth.
- In FY2025, shareholders' equity increased 25.1% year-over-year.
- Ranks #69 out of 166 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | +25.1% |
| FY2024 | $1.2B | +65.4% |
| FY2023 | $732.7M | +53.8% |
| FY2022 | $476.4M | -14.4% |
| FY2021 | $556.3M | -7.8% |
| FY2020 | $603.6M | +695.3% |
| FY2019 | $75.9M | -64.2% |
| FY2018 | $212.1M | +33.8% |
| FY2017 | $158.5M | +151.2% |
| FY2016 | $63.1M | +85.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026